1,152 material Form 8-K filings that 918 companies we cover made with the SEC in October 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Dynamix Corporation III, a Cayman Islands blank-check company (SPAC), closed its initial public offering on October 31, 2025, selling 20,125,000 units at $10.00 each for gross proceeds of $201,250,000, including units from the underwriters' full option exercise. The $201,250,000 was placed in a trust account, and the funds generally cannot be released until a business combination, a shareholder-vote redemption, or a failure to complete a combination within 24 months.
20,125,000 units sold at $10.00 each, including 2,625,000 units from the full exercise of the underwriters' option, for gross proceeds of $201,250,000
$201,250,000 placed in trust with Odyssey Transfer and Trust Company, including $194,975,000 of IPO net proceeds and $6,275,000 from private placement warrants
6,275,000 private placement warrants sold at $1.00 each to the sponsor and underwriters, for gross proceeds of $6,275,000 on October 29, 2025
Diaco Aviki, Tyler Crabtree and James Henderson appointed to the board on October 29, 2025; units began trading on Nasdaq as DNMXU on October 30, 2025
LaFayette Acquisition Corp. closed its initial public offering on October 27, 2025, selling 11,500,000 units at $10.00 per unit for $115 million in gross proceeds, including units from the full exercise of the underwriters' over-allotment option. A private placement of 380,000 units raised $3.8 million at the same time, and the full $115 million was placed in a trust account for public shareholders. The company has 21 months from the closing to complete a business combination, and the filing states there is no assurance it will do so.
11,500,000 units sold at $10.00 each, including 1,500,000 units from the over-allotment option exercised in full
380,000 private placement units sold at $10.00 each for $3.8 million to LaFayette Sponsor LLC and EarlyBirdCapital, Inc.
$115 million ($10.00 per unit) held in trust; transaction costs totaled $6,731,306
Combination period runs 21 months from the October 27, 2025 closing
California Resources Corporation entered into a seventh amendment to its credit agreement on October 29, 2025, adding new lenders and increasing the aggregate elected commitment amount from $1.15 billion to $1.45 billion. The filing describes the change as a financing update to the existing facility, and the full amendment is filed as Exhibit 10.1.
Aggregate elected commitments rose from $1.15 billion to $1.45 billion under the Seventh Amendment.
The amendment, dated October 29, 2025, adds certain new lenders to the facility.
Administrative agent and collateral agent is Citibank, N.A.; the original credit agreement is dated April 26, 2023.
HCA Inc., a wholly owned subsidiary of HCA Healthcare, completed a public offering of $3.25 billion in senior unsecured notes on October 31, 2025, in four tranches maturing between 2030 and 2055. HCA Healthcare fully and unconditionally guarantees the notes, which increases the company's long-term debt obligations, and the filing does not state how the proceeds will be used.
Four tranches: $500 million 4.300% notes due November 15, 2030; $1.0 billion 4.600% notes due 2032; $1.0 billion 4.900% notes due 2035; and $750 million 5.700% notes due November 15, 2055.
Interest is payable semi-annually on May 15 and November 15, starting May 15, 2026.
HCA Healthcare guarantees the notes on a senior unsecured basis; underwriters J.P. Morgan, Citigroup, Mizuho and Wells Fargo were representatives under an October 27, 2025 underwriting agreement.
If both a qualifying ratings downgrade and certain changes of control occur, holders may require repurchase at 101% of principal plus accrued interest.
Graphic Packaging's main operating subsidiary entered an amendment to its credit agreement providing up to $400.0 million in a delayed draw incremental term loan, available to draw between March 15, 2026 and April 15, 2026. The loan matures June 30, 2027, and its proceeds are to repay in full the company's 1.512% Senior Secured Notes due 2026.
Up to $400.0 million delayed draw term loan, drawable once between March 15, 2026 and April 15, 2026
Loan matures June 30, 2027 and bears floating interest of SOFR plus 1.00% to 1.75%, or Base Rate plus 0.00% to 0.75%, based on leverage
Proceeds will repay in full the 1.512% Senior Secured Notes due 2026, plus transaction costs
Loan is secured by a first-priority lien on substantially all personal property assets of the borrower and guarantors
Morningstar entered a new $1.5 billion multi-currency credit agreement with Bank of America, N.A. as administrative agent, and terminated its existing credit agreement dated May 6, 2022. The filing says the new facility can refinance existing debt and fund corporate purposes, and that $170.0 million was outstanding under the revolving facility as of October 31, 2025. The agreement adds covenants, including a net leverage limit of 3.50 to 1.00 and an interest coverage minimum of 3.00 to 1.00, and restricts dividend payments.
Facility totals up to $1.5 billion: $750.0 million five-year revolver, $375.0 million five-year delayed draw term facility, and $375.0 million three-year term facility
$170.0 million outstanding under the revolving facility as of October 31, 2025, described as a rollover of prior borrowings
Covenants require consolidated net leverage of no more than 3.50 to 1.00 and interest coverage of at least 3.00 to 1.00
Interest margins range from 1.05% to 1.425%, based on the consolidated net leverage ratio; the agreement also restricts dividend payments
On October 31, 2025, NiSource entered into equity distribution agreements with eleven banks for an at-the-market program to sell up to $1.5 billion of common stock through December 31, 2028. The program replaces a $900 million program set up on February 22, 2024, and includes about $47.5 million of unsold shares from that program. The company has no obligation to sell any shares, and any sales would add to shares outstanding, while proceeds are intended for general corporate purposes.
Program covers up to $1.5 billion gross sales price of common stock through December 31, 2028
Sales agents receive commissions of up to 2% of sales prices
Replaces the $900 million program established February 22, 2024, which had about $47.5 million unsold
Proceeds intended for general corporate purposes, including capital expenditures, working capital and repaying existing debt
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.